Scope of the Study
The global virus testing market is hereby expected to grow with a highly robust CAGR over the forecasted period due to the increasing consumer preference for self-diagnostic techniques. In addition, to these many of the leading companies are at present continuously investing in the research and development sector so as to develop new testing kits for the various viral diseases. Viral infections can be diagnosed by testing blood, the body fluids, or samples from the infected area of the body that are further examined using an electron microscope. Viral infections like measles and rubella are usually diagnosed on the basis of their symptoms. Some of the highly serious viral infections are diagnosed by the means of examining the blood or body fluids. The prevalence of infectious diseases has increased significantly over the past ten years. The growing preference for self-diagnosis of viral diseases and the increased detection of new infectious viruses are important factors that should drive the market for diagnostic kits for virus tests in the near future. However, complex regulatory scenarios regarding the approval of diagnostic tests for viral infections and rising healthcare costs are expected to limit the market in the forecast period.
The market study is being classified by Type (Direct Fluorescent Antibody (DFA) Test, Immunochromatographic Assay, RT-PCR-Based Test, Agglutination Assay and Flow-Through Assay/Solid-Phase Assay), by Application (Individual and Commercial) and major geographies with country level break-up.
Roche Holding AG (Switzerland), Agilent Technologies (United States), Thermo Fisher Scientific (United States), QIAGEN International (Netherlands), Lonza Group AG (Switzerland), Wuxi Pharmatech (Cayman), Merck (United States), Eurofins Scientific (Luxembourg), General Electric (United States), Danaher Corporation (United States), Bio-Rad Laboratories (United States) and BD (United States) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Biospherix (United States), Novogene Corporation (China) and Sartorius (Germany).
The companies are now exploring the market by adopting mergers & acquisitions, expansions, investments, new developments in existing products, and collaborations as their preferred strategies. The players are also exploring new geographies and industries through expansions and acquisitions so as to avail a competitive advantage through combined synergies. Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Viral Testing market throughout the predicted period.
AdvanceMarketAnalytics has segmented the market of Global Viral Testing market by Type, Application and Region.
On the basis of geography, the market of Viral Testing has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
- Rising Prevalence of the Disease across the Globe
- Increasing Demand for More Rapid Diagnostic Test Kits for Influenza
- Rising Prevalence of Viral Diseases
- Emergence and Detection of New Viruses
- Rising Adoption of Self-Diagnostic and Cost-Effective Test Kits by Patients As Well As Physicians
- Complex Regulatory Scenario Regarding the Approval for Diagnostic Tests for Viral Infections
- Increasing Health Care Costs
- Funding By Public and Private Players for Research and Development of Novel Virus Diagnostic Techniques
- Growth in Favorable Reimbursement Policies
- Government Participation in the Prevention and Control of Infectious Diseases
- Unawareness about Viral Testing in Under Developed Regions
Key Target AudienceProviders of Viral Testing, End-Users, Potential Investors, Market Research Firms, Regulatory Bodies and Others
Customization in the Report Available:The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase